Journey Medical Corporation to Participate in October 2025 Investor Conferences

Rhea-AI Summary

Journey Medical (Nasdaq: DERM) said its management team will participate in two investor conferences in October 2025 in New York City.

Events and formats:

• ROTH Healthcare Opportunities Conference — Thursday, October 9, 2025 — 1x1 meetings.
• The ThinkEquity Conference — Thursday, October 30, 2025 — presentation and 1x1 meetings.

The company will engage investors through one-on-one meetings and a public presentation on the listed dates.

SCOTTSDALE, Ariz., Oct. 08, 2025 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical” or “the Company”) (Nasdaq: DERM), a commercial-stage pharmaceutical company primarily focused on selling and marketing U.S. Food and Drug Administration (“FDA”)-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that members of Journey Medical’s management team will participate in two October 2025 investor conferences.

Details of the events are as follows:

4th Annual ROTH Healthcare Opportunities Conference
Date: Thursday, October 9, 2025
Location: New York City
Format: 1x1 Meetings

The ThinkEquity Conference
Date: Thursday, October 30, 2025
Location: New York City
Format: Presentation and 1x1 Meetings

About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on the selling and marketing of FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets eight branded FDA-approved prescription drugs that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). For additional information about Journey Medical, visit www.journeymedicalcorp.com.

Company Contact:
Jaclyn Jaffe
(781) 652-4500
ir@jmcderm.com 

Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com 

FAQ

When will Journey Medical (DERM) attend the ROTH Healthcare Opportunities Conference in 2025?

Journey Medical management will attend the ROTH Healthcare Opportunities Conference on Thursday, October 9, 2025 in New York City for 1x1 meetings.

What is Journey Medical's schedule at The ThinkEquity Conference for October 2025?

Journey Medical is scheduled for a presentation and 1x1 meetings on Thursday, October 30, 2025 in New York City.

How can investors access Journey Medical's ThinkEquity presentation on October 30, 2025?

The company indicated it will present at the conference; investors should check Journey Medical investor relations or the conference website for webcast or replay availability.

Which Journey Medical executives will attend the October 2025 investor conferences?

The announcement states that members of Journey Medical's management team will participate; specific executive names were not provided.

Will Journey Medical (DERM) hold one-on-one meetings at the October 2025 conferences?

Yes. The company listed 1x1 meetings at both the ROTH conference (October 9) and The ThinkEquity Conference (October 30).